肺癌筛查的卫生经济学评价研究  

Research on the Health Economic Evaluation of Lung Cancer Screening

作　　者：张温馨 潘宇[1] 李峒作 王亮[1] 马原[1] 寇静恬 唐文祥 迟航 Zhang Wenxin;Pan Yu;Li Dongzuo;Wang Liang;Ma Yuan;Kou Jingtian;Tang Wenxiang;Chi Hang(The First Affiliated Hospital of Harbin Medical University,Harbin,150001,China;不详)

机构地区：[1]哈尔滨医科大学附属第一医院,哈尔滨150001

出　　处：《中国卫生经济》2023年第8期78-81,共4页Chinese Health Economics

摘　　要：目的:对肺癌筛查进行成本-效果分析,评价肺癌筛查的经济性。方法:构建肺癌筛查决策树模型,对肺癌筛查及不筛查两种策略进行投入产出分析,评价两种策略的成本与健康产出,并进行增量成本-效果分析,判断肺癌筛查策略的经济性。结果:肺癌筛查策略与不筛查策略相比,每多获得1个寿命年的成本为93153元。结论:根据WHO推荐阈值,在人群中实施肺癌筛查是具有成本-效果的,应在人群中积极推广肺癌筛查。Objective:Conduct a cost-effectiveness analysis of lung cancer screening to evaluate the economic viability of lung cancer screening.Methods:A decision tree model for lung cancer screening was constructed to analyze the input-output of lung can-cer screening and non-screening strategies,and to evaluate the cost and health outcomes of these two strategies.Incremental cost ef-fectiveness analysis was performed to determine the economics of lung cancer screening strategies.Results:The cost of gaining an additional year of life through lung cancer screening strategy compared to non-screening strategy is 93153 yuan.Conclusion:Ac-cording to the WHO recommended threshold,implementing lung cancer screening in the population is cost-effective and should be actively promoted.

关 键 词：肺癌筛查 成本-效果分析 决策树模型 

分 类 号：R1-9[医药卫生—公共卫生与预防医学] R224.9